|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
N/A |
| Shares
Out: |
239,210,000 |
| Market
Cap: |
478.42(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $1.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market™ technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane™, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane™ sweetener.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
17,155 |
| Total Buy Value |
$0 |
$0 |
$0 |
$69,135 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
20,999 |
4,403,696 |
| Total Sell Value |
$0 |
$0 |
$19,949 |
$15,923,478 |
| Total People Sold |
0 |
0 |
1 |
6 |
| Total Sell Transactions |
0 |
0 |
1 |
15 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kung Frank |
Director |
– • – |
2018-11-01 |
4 |
A |
$0.00 |
$0 |
I/I |
667 |
667 |
|
- |
|
| Kung Frank |
Director |
– • – |
2018-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(667) |
3,599 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2018-11-01 |
4 |
D |
$7.53 |
$3,471 |
D/D |
(461) |
743,252 |
|
- |
|
| Cherry Joel |
President of R&D |
• – – |
2018-11-01 |
4 |
D |
$7.53 |
$4,292 |
D/D |
(570) |
269,583 |
|
- |
|
| Total Raffinage Chimie |
Director by Deputization |
– • • |
2018-10-16 |
4 |
OE |
$4.40 |
$15,174,812 |
D/D |
3,448,821 |
7,727,367 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2018-10-15 |
4 |
AS |
$7.50 |
$38,952 |
D/D |
(5,195) |
743,713 |
|
- |
|
| Alvarez Eduardo |
Chief Operating Officer |
• – – |
2018-10-01 |
4 |
D |
$7.49 |
$73,664 |
D/D |
(9,835) |
322,042 |
|
- |
|
| Alvarez Eduardo |
Chief Operating Officer |
• – – |
2018-09-05 |
4 |
B |
$8.45 |
$100,326 |
D/D |
11,877 |
331,877 |
2.74 |
- |
|
| Valiasek Kathleen |
Chief Financial Officer |
• – – |
2018-08-22 |
4 |
B |
$7.20 |
$100,800 |
D/D |
14,000 |
228,630 |
2.74 |
- |
|
| Kung Frank |
Director |
– • – |
2018-08-20 |
4 |
OE |
$4.40 |
$7,175,758 |
I/I |
1,630,854 |
676,448 |
|
- |
|
| Kung Frank |
Director |
– • – |
2018-08-20 |
4 |
S |
$6.22 |
$7,139,941 |
I/I |
(1,148,122) |
478,571 |
|
- |
|
| Kung Frank |
Director |
– • – |
2018-08-17 |
4 |
OE |
$4.26 |
$22,032,979 |
I/I |
5,042,437 |
617,877 |
|
- |
|
| Kung Frank |
Director |
– • – |
2018-08-17 |
4 |
S |
$6.22 |
$17,268,128 |
I/I |
(2,776,762) |
139,306 |
|
- |
|
| Doerr L John |
Director |
– • • |
2018-08-17 |
4 |
OE |
$0.00 |
$21,463,658 |
I/I |
6,983,603 |
7,852,775 |
|
- |
|
| Doerr L John |
Director |
– • • |
2018-08-17 |
4 |
S |
$6.22 |
$30,331,488 |
I/I |
(4,877,386) |
5,746,558 |
|
- |
|
| Yang Patrick Y |
Director |
– • – |
2018-08-13 |
4 |
B |
$7.66 |
$114,900 |
D/D |
15,000 |
51,932 |
2.39 |
- |
|
| Yang Patrick Y |
Director |
– • – |
2018-08-09 |
4 |
B |
$7.71 |
$77,100 |
D/D |
10,000 |
36,932 |
2.39 |
- |
|
| Mills Ateven Richard |
Director |
– • – |
2018-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
2,266 |
|
- |
|
| Kelsey Nicole |
General Counsel and Secretary |
• – – |
2018-08-01 |
4 |
D |
$6.96 |
$16,843 |
D/D |
(2,420) |
118,580 |
|
- |
|
| Doerr L John |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
5,532 |
|
- |
|
| Piwnica Carole |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
5,532 |
|
- |
|
| Williams R Neil |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
5,132 |
|
- |
|
| Eykerman Philip |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
5,399 |
|
- |
|
| Kung Frank |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
4,266 |
|
- |
|
| Al Thani Sheikh Abdullah Bin Khalifa |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,266 |
5,332 |
|
- |
|
402 Records found
|
|
Page 7 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
